Mcallen, TXNCT07812090Now EnrollingIRB Ready

Diabetic Macular Edema (DME) Clinical Trial in Mcallen, TX

Access cutting-edge diabetic macular edema (dme) treatment through this phase 2 clinical trial at a research site in Mcallen. Study-provided care at no cost to qualified participants.

Sponsored by BioAge Labs, Inc.

Quick Self-Assessment

See if you qualify for this Mcallen location

Preparing your pre-screening questions…

Expert Care in Mcallen

Access diabetic macular edema (dme) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic macular edema (dme) treatment provided free

Apply for This Mcallen Location

Check if you qualify for this diabetic macular edema (dme) clinical trial in Mcallen, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Mcallen

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Mcallen site if eligible
  4. 4Begin participation

About This Diabetic Macular Edema (DME) Study in Mcallen

The purpose of this study is to learn about the effects of BGE-102 on change in vision in participants with center-involved diabetic macular edema (CI-DME). BGE-102 decreases inflammation which may improve vision or slow the progression of vison loss in those with CI-DME. Participants will be randomized to one of 3 arms and receive either BGE-102 in combination with an anti-vascular endothelial growth factor (anti-VEGF) drug, BGE-102 in combination with sham injection, or BGE-102 placebo in combination with an anti-VEGF drug. This study will also evaluate safety and tolerability of BGE-102.

Sponsor: BioAge Labs, Inc.

Who Can Participate

Inclusion Criteria

Adults 18-75 years of age
Type 1 or Type 2 Diabetes diagnosis
Diabetic Macular Edema (DME) affecting the center of vision
Study Eye may be treatment naïve (never received treatment) or previously treated and if previously treated, meets washout requirements
Acceptable Vision as measured by an eye chart
Visual Acuity and retinal thickness as measured by an eye scan, results meeting eligibility criteria
Willing to use birth control, if applicable

Exclusion Criteria

Significant ocular disease, condition, or prior ocular treatment and/ or procedure that could affect vision, study assessments, or participant safety, including failure to meet required treatment washout periods
Macular edema in the study eye due to causes other than DME, such as retinal vein occlusion, uveitis, neovascular age-related macular degeneration
Significant macular ischemia in the study eye that would limit visual improvement as assessed by the Investigator and confirmed by the Reading Center
Uncontrolled diabetes
Uncontrolled blood pressure
Medically unstable cardiac conditions and/or medically important ECG abnormalities.
Relevant medical or psychiatric condition(s) that put the participant at risk or will make implementation of the protocol or interpretation of the study difficult.
Women who are pregnant or nursing

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Mcallen?

Yes, this clinical trial (NCT07812090) has an active research site in Mcallen, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Macular Edema (DME) Treatment Options in Mcallen, TX

If you're searching for diabetic macular edema (dme) treatment options in Mcallen, TX, this clinical trial (NCT07812090) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Mcallen research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced diabetic macular edema (dme) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic macular edema (dme) clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Mcallen, TX

See all essential tremor clinical trials recruiting in Mcallen — not just this study.

Browse Essential Tremor Trials in Mcallen →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Mcallen?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Mcallen, TX